Andira Pharmaceuticals Achieves Remarkable Breast Cancer Tumor Regression with Lead Oncology Candidate XOXO4
Andira Pharmaceuticals Achieves Remarkable Breast Cancer Tumor Regression with Lead Oncology Candidate XOXO4
October 25, 2023 13:20 ET | US Capital Global
San Francisco, California, USA, Oct. 25, 2023 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an affiliate of US Capital Global, recently launched an investment opportunity of up to $5 million...
Kajawood Studios
US Capital Global Securities Finances and Advises on $50 Million Debt and Equity for Kajawood Studios in Finland
September 27, 2023 15:50 ET | US Capital Global
San Francisco, California, USA, Sept. 27, 2023 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an affiliate of US Capital Global, has provided equity financing of $10 million and advised on...
CardLab
US Capital Global Securities Advises on $10MM Financing for Multi-Award-Winning Smart Card Cybersecurity Firm
September 18, 2023 06:48 ET | US Capital Global
San Francisco, California, USA, Sept. 18, 2023 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an affiliate of US Capital Global, has provided customized financial advisory services for Danish...
Fulfilling the potential of life-saving medications
US Capital Global Engaged by PlantForm Corporation as Strategic Advisor on $25 Million Capital Formation
August 31, 2023 07:35 ET | US Capital Global
San Francisco, California, USA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- US Capital Global has been engaged by PlantForm Corporation (“PlantForm” or the “Company”) as its strategic financial advisor on a...
Socal Safe Company
US Capital Global Provides Multi-Million-Dollar Sell-Side M&A Advisory to Socal Safe Company
August 24, 2023 08:47 ET | US Capital Global
San Francisco, California, USA, Aug. 24, 2023 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an SEC-registered, FINRA-member broker-dealer affiliate of global private financial group US...
Andira Pharmaceuticals’ US Patent Allowed
Andira Pharmaceuticals’ US Patent Allowed in Breakthrough Therapeutic Treatment to Address Deadly Antibiotic-Resistant Infections
August 10, 2023 08:00 ET | US Capital Global
San Francisco, California, USA, Aug. 10, 2023 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an affiliate of US Capital Global, recently launched an investment opportunity of up to $5 million...
Red Coast Industries Limited
US Capital Global Advises on Multi-Million-Pound Acquisition of Premier Sealant by Red Coast Industries
July 25, 2023 05:27 ET | US Capital Global
San Francisco, California, USA, July 25, 2023 (GLOBE NEWSWIRE) -- US Capital Global has supported Red Coast Industries Limited, a UK-based industrial investment firm, as debt advisor in its...
Sal Saqeb – Vice President at US Capital Global
US Capital Global Expands Its Presence in Asia with Appointment of Vice President Sal Saqeb
July 07, 2023 10:08 ET | US Capital Global
San Francisco, California, USA, July 07, 2023 (GLOBE NEWSWIRE) -- US Capital Global is pleased to announce the appointment of Sal Saqeb as Vice President. With an impressive background in finance...
Investment opportunity of up to $5 million in Andira Pharmaceuticals
US Capital Global Securities Launches $5 Million Equity Offering for Canadian Health Science Pioneer Andira Pharmaceuticals
June 14, 2023 09:00 ET | US Capital Global
San Francisco, California, USA, June 14, 2023 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an affiliate of US Capital Global, is offering eligible investors an investment opportunity of up...
Launch Event
US Capital Global Opens a New Regional Office in New York City
June 06, 2023 10:35 ET | US Capital Global
New York, USA, June 06, 2023 (GLOBE NEWSWIRE) -- US Capital Global, a leading private financial group, is pleased to announce the opening of its new Northeast regional office in New York City,...